abstract |
"SALT, PROCESS FOR THE MANUFACTURE AND USE OF THE SAME, PHARMACEUTICAL FORMULATION, AND, PROCESS FOR THE PREVENTION OR TREATMENT OF CNS DISORDERS AND RELATED MEDICAL DISTURBANCES". A new salt, (R) -3-N, N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen tartrate, particularly the (2R-3R)-tartrate of the same , more particularly still the (R) -3-N, N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide (2R, 3R)-tartrate monohydrate, processes for the manufacture of said tartrate salt, the use of salt in medicine, the use of tartrate salt in the manufacture of pharmaceutical formulations, and a process for treating CNS disorders by administering the tartrate salt to a patient in need of such treatment. |